Biosensia is a Point-of-Care In vitro diagnostics company located at NovaUCD on the campus of University College Dublin, Ireland.[1]
Founded in 2006, Biosensia has developed an integrated Point-of-Care (POC) in-vitro diagnostic test platform which delivers a rapid test result and has a broad range of diagnostic applications.[2]
Biosensia has secured the investment of three venture capital companies and Enterprise Ireland:[3]